NCT02631057 - Length of Stay in NVAF Patients Hospitalized and Initiated With Dabigatran or Warfarin in Japan | Biotech Hunter

Enrollment

4,313

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

September 7, 2016

Study Completion Date

September 7, 2016

Conditions

Atrial Fibrillation

Interventions

DRUG

Dabigatran

Dabigatran 110 mg capsule twice a day or 75 mg x 2 capsules twice a day

DRUG

Warfarin

Warfarin tablet (adjustment by each patients)

Trial Locations (2)

NISED Center, Tokyo, Shinagawa

1160.254.81001 Boehringer Ingelheim Investigational Site, Shinagawa City